Danish company Kvantify has launched Kvantify Qrunch, a new technology designed to perform quantum chemistry calculations on real quantum computers. Released on November 19, 2025, this software aims to address the challenges of utilizing increasingly powerful, yet immature, quantum hardware by providing accessibility for non-quantum experts, scalability for real-world problem sizes, and acceptable cost-to-value ratios. Kvantify Qrunch has the potential to transform molecular discovery, enabling the creation of new drugs, materials, and energy solutions through the coupling of quantum and classical computing. This launch marks a critical milestone in mediating the transformation of molecular discovery via quantum computing.
Kvantify Qrunch Software and its Capabilities
Kvantify has launched Kvantify Qrunch software, a technology designed for performing quantum chemistry calculations on actual quantum computers. Released in November 2025, the software aims to bridge the gap between powerful, yet immature, quantum hardware and practical application, particularly within molecular discovery. Kvantify emphasizes accessibility, enabling researchers without quantum computing expertise to utilize the technology for areas like drug discovery and materials science.
Kvantify Qrunch is intended to transform how molecular research is done by combining quantum and classical computing approaches. For companies like Novonesis, this capability promises reduced project timelines and the ability to model larger, commercially relevant molecules. Specifically, Novonesis aims to use Qrunch to better understand enzyme behavior during catalysis, potentially improving existing enzyme products and gaining insights into fundamental biological processes.
The software is launching on quantum computers provided by IQM, a Finnish-German superconducting quantum computing company. This partnership establishes Kvantify and IQM as a European force in quantum computing, with IQM noting that performant quantum software like Qrunch is crucial for commercializing the technology. Kvantify, founded in 2022 with 49 employees, focuses specifically on the life science industry and early drug discovery.
Partnership with IQM Quantum Computers
Kvantify has launched its quantum chemistry software, Qrunch, on quantum computers provided by IQM Quantum Computers. This partnership establishes Kvantify and IQM as a European champion in the field, combining software development with superconducting quantum computing hardware. According to IQM’s Co-CEO Jan Goetz, performant quantum software is crucial for commercializing quantum computing, and Qrunch delivers that capability.
Qrunch is designed to facilitate accessible, scalable, and cost-efficient quantum chemistry calculations. This software aims to transform molecular discovery, with potential applications in creating new drugs, materials, and energy solutions by combining quantum and classical computing. Novonesis is among the first to test Qrunch, hoping to reduce project timelines and model larger molecules relevant to commercial applications.
IQM Quantum Computers, a Finnish-German company, is a global leader in superconducting quantum computing and provides the integrated hardware for Qrunch. The collaboration intends to strengthen the European quantum ecosystem by leveraging synergies between IQM’s hardware and Kvantify’s software. Kvantify, founded in 2022 with 49 employees, focuses on the life science industry, particularly early drug discovery.
The potential of Kvantify Qrunch is enormous. We designed it for accessibility, so that users that are not quantum experts can start using this powerful technology.
Professor Nikolaj Zinner, CSO at Kvantify
Kvantify Company Overview and Focus
Kvantify is a Danish company established in 2022, specializing in software development for both quantum and classical computers. With a workforce of 49 employees, the company concentrates its efforts on the life science industry, particularly in the initial stages of drug discovery. Kvantify aims to bridge the gap between quantum computing power and practical applications, focusing on accessibility for researchers without specialized quantum expertise. Contact for the company is available at contact@kvantify.dk.
Launched in November 2025, Kvantify Qrunch is a technology designed to perform quantum chemistry calculations on real quantum computers. This software addresses key challenges in utilizing quantum hardware, prioritizing accessibility, scalability for real-world problems, and cost-to-value ratios. The launch is described as a critical milestone in transforming molecular discovery through quantum computing, enabling expanded scope and reduced timelines for pharmaceutical and materials science projects.
Kvantify partners with IQM Quantum Computers, a leader in superconducting quantum computing, to provide integrated hardware for Qrunch. This collaboration aims to establish a European champion in quantum computing, strengthening the ecosystem by combining hardware and software solutions. Novonesis, a biotech giant, is among the first to test Qrunch, hoping to improve enzyme efficiency and gain deeper insights into fundamental biological processes via more detailed catalytic behavior analysis.
